Concepedia

Sandra J. Casak

SJ

Statistics

Publications

27

Citations

1.3K

H-Index

20

Active since

1994

Affiliations

Center for Drug Evaluation and Research(Current)

United States Food and Drug Administration

Garrahan Hospital

Sandra J. Casak is an author at Center for Drug Evaluation and Research specializing in medicine, oncology, and chemotherapy.

Publications per year

1994–2024

27

Publications

27

FDA Approval Summary: Atezolizumab Plus Bevacizumab for the Treatment of Patients with Advanced Unresectable or Metastatic Hepatocellular Carcinoma

Sandra J. Casak, Martha Donoghue, Lola A. Fashoyin‐Aje et al. · Clinical Cancer Research · 2020 · 178 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

FDA Approval Summary: Pembrolizumab for the First-line Treatment of Patients with MSI-H/dMMR Advanced Unresectable or Metastatic Colorectal Carcinoma

Sandra J. Casak, Leigh Marcus, Lola A. Fashoyin‐Aje et al. · Clinical Cancer Research · 2021 · 178 citations · Full text

Medicine, Oncology, Pharmacotherapy +11

Treatment of overt extraocular retinoblastoma

Guillermo Chantada, Adriana Fandiño, Sandra J. Casak et al. · Medical and Pediatric Oncology · 2003 · 128 citations

Medicine, Oncology, Surgery +15

FDA Approval Summary: Ramucirumab for Gastric Cancer

Sandra J. Casak, Ibilola Fashoyin-Aje, Steven J. Lemery et al. · Clinical Cancer Research · 2015 · 100 citations

Medicine, Oncology, Pharmacology +12

Nasopharyngeal carcinoma in childhood and adolescence

Pedro Zubizarreta, Gabriela D'Antonio, Elsa Raslawski et al. · Cancer · 2000 · 84 citations

Medicine, Oncology, Pediatrics +12

1–5 of 27